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Smm_ary The risk of cancer of the cervix is linked with sexual behaviour. Although infectious agents such as
human papillomaviruses (HPVs) are implicated, these alone may be insufficient to induce the disease. We have
investigated the potential role of oxidation products of the polyamines spermine and spermidine and the
diamine putrescine in seminal plasma (SP) as co-factors in the development of cervical cancer. These amines
are oxidised by polyamine oxidase (PAO) and diamine oxidase (DAO) to generate oxygen radicals and
hydrogen peroxide, reactive aldehydes and acrolein, which are likely to exert local mutagenic, cytotoxic and
immunosuppressive effects in vivo. Using a chemiluminescence assay, we determined the levels of these amines
in 187 samples of SP. Spermine plus spermidine, as substrates for PAO. were present in a range equivalent to
0-4.8 mg ml-' spermine. Putrescine, as a substrate for DAO, was detectable in only 4 of 40 samples assayed
(range 0-168 pg ml -') and constitutes a minor component of the oxidisable content of SP. Cervical mucus
(126 samples) was assayed for the presence of PAO and DAO. Both enzymes were present in 14.3% of the
samples, PAO only in 21.4%, DAO only in 15.1% and neither enzyme in 49.2%. PAO levels ranged from 0 to
0.828 pmol peroxide generated min-' mg'I mucus and DAO levels ranged from 0 to 7.0 pmol peroxide
generated min-' mg-' mucus. These results suggest that sexual activity in the absence of physical bamrer
contraception may lead to the generation of mutagenic and immunosuppressive polyamine oxidation products
within the female genital tract. We thus propose that women with high levels of PAO and/or DAO in their
cervical mucus may be at increased risk of cervical cancer, especially if the male partner's SP shows high
polyamine levels. HPV infection may synergise with the effects of polyamine oxidation by suppressing
apoptosis in keratinocytes carrying potentially oncogenic mutations, leading to the survival and proliferation
of transformed cells in the cervix.
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The aetiology of cervical cancer is still the subject of debate.
Strong epidemiological evidence has linked cervical cancer
risk with sexual behaviour (Franco, 1991; Joffe et al., 1992),
suggesting the involvement of a transmissible agent. How-
ever, simple models based upon infectious agents alone, such
as human papillomavirus (HPV), have been shown to be
inadequate. HPV infection is still much more common than
the occurrence of cervical intraepithelial neoplasia (CIN) and
invasive cervical cancer (Schiffman, 1992); most women who
are HPV positive show no evidence of cervical abnormalities
(De Villiers et al., 1987; Meanwell et al., 1987; Reeves et al.,
1987) and only a small proportion of women with HPV
develop cervical cancer (Mitchell et al., 1986). Furthermore,
the long latent penrods (20-50 years) between HPV infection
and the development of cancer (zur Hausen, 1986) suggests
that HPV alone is insufficient to induce cervical cancer. A
number of additional aetiological factors have been proposed
as increasing the risk of developing the disease. These include
heavy smoking (Winkelstein, 1990), the long-term use of oral
contraceptives (Jones et al., 1990; Gram et al., 1992), dietary
factors (Potischman, 1993), concomitant infection with
herpes simplex type 2 (Hildesheim et al., 1991) or other
sexually transmitted diseases (Guijon et al., 1985; La Vecchia
et al., 1986; Herrero et al., 1990), and the immunosuppressed
states associated with organ transplantation, pregnancy, or
acquired immunodeficiency disease (Schneider et al., 1987;
Alloub et al., 1989; Henry et al., 1989).
Risk of acquisition of sexually transmitted disease cor-
relates with sexual activity: intercourse with a large number
of sexual partners increases the chance of exposure to such
transmissible agents. However, risk of cervical disease is
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more closely related to the number of steady partners with
relationships lasting more than 3 months than to the number
of non-steady partners, an effect more apparent for those
who had multiple steady partners at younger ages (Herrero et
al., 1990). This suggests the need for more prolonged or
repeated exposure to a partner who carries a transmissible
agent. Attention has thus recently turned to investigation of
chemical components of semen which may act together with
infectious agents as co-factors in the development of cervical
cancer or as inducers of cancer in their own right.
Seminal plasma (SP) has potent immunosuppressive
activity. A number of SP components have been demon-
strated to be capable of modulating a variety of
immunological functions (Quayle et al., 1989; Ablin et al.,
1990; Kelly et al., 1991; Skibinski et al., 1992). The
polyamines spermine, spermidine and putrescine occur at
high concentrations in SP (Williams-Ashman and Lockwood,
1970); their physiological function here is unknown, although
it has been suggested that they inhibit the coagulation of
semen in the male urethra (see Oefner et al., 1992).
Polyamines have been shown to mediate immunosuppressive
effects in vitro through their oxidation products (Allen and
Roberts, 1987; Vallely et al., 1988; Quan et al., 1990); hyd-
rogen peroxide, acrolein and reactive aldehydes generated by
enzymic oxidation of polyamines show cytotoxic properties
(Averill-Bates et al., 1993) as well as the ability to cause
DNA strand breaks (Henle et al., 1986) and chromatid aber-
rations (Bouzyk and Rosiek, 1988) and to induce program-
med cell death (Parchment and Pierce, 1989; Gramzinski et
al., 1990). The presence in the female genital tract of enzymes
catalysing the oxidation of polyamines from a male partner's
semen could thus lead both to local immunosuppression and
to exposure of the cervical epithelial cells to genotoxic agents.
Either or both of these effects could be significant in the
initiation and progression of cervical cancer.
The relevance of polyamine oxidation in vivo to the
aetiology of cervical malignancy has not previously been
examined. The present study was undertaken to investigate
the possible involvement of polyamines present in SP and of
polyamine oxidation enzymes in cervical mucus as co-factors
in the development of cervical carcinoma.
Maedak and
A total of 120 seminal plam samples were donated from
males attending the Sheffield Fertility Centre, Sheffield; an
additional 67 samples were obtained from the partners of
women in a cas-control study of vaginitis at the Depart-
ment of Family Practice, University of Michigan Medical
School, Ann Arbor, Michigan, USA. Fresh ejaculates were
centrifuged and the supernatants stored at - 80 C until
assayed. No decrease in oxidisable polyamine level was
observed in samples stored in this way for several months.
One hundred and twenty-six cervical mucus samples were
obtained from women attending the Departnent of Genito-
Urinary Medicine, Royal Hallamshim HospitaL Sheffield.
TIhe age range was 16-56 years (median 23 years). The
cim were colleted during routine examination of the
cervix using a disposable plastic loop which was used to
transfer mucus to preweighed vials containing 0.5 ml of
10mM Tris-HCI pH 7.5/150mm sodium chloride. The vials
were reweighed to estimate the weight of mucus colleted
(10-50mg). The samples were stored overnight at 4-C and
assayed the following day.
Spermine tetrahydrochloride, diamine oxidase, coflagase,
hyaluronidas, microperoxidase, luminol and hydrogen perox-
ide were purchased from Sigma, Poole, Dorset.
Polyamine oxidase (PAO) was purified from newborn calf
serum on a 30 x 1 cm column of DEAE-Sepharose Fast
Flow (Pharmacia) using a Pharmacia FPLC apparatus. The
column was eluted with a gradient of 0-0.1 M sodium
chloride in 75 ml, then 0.1-0.5M sodium chloride in 125 ml,
then 50 ml of 0.5 M sodium chloride. Fractions containing
PAO were identified using a modified form of the colori-
metric assay described by Aarsen and Kemp (1964), using
spermidine as substrate. The PAO-containing fractions were
pooled for use in the assay of spermine and spermidine.
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the chemiluminescence assay as follows: 15 pl of diluted cer-
vical mucus was incubated in the presence of 6 ig ml1' sper-
mine for 24 h at 37C in a stoppered cuvette for the detection
of PAO or 30 sgmnl putrescine for l h at 37C for the
detection of DAO. Microperoxidase (final concentration
lOgml-') and luminol (final concentration 18 &gml-')
were added and the samples read as above. Integral values
were calibrated against standards containing known concen-
trations of hydrogen peroxide. Enzyme activities were ex-
pressed as pmols hydrogen peroxide generated min-'mg'
cervical mucus.
Estimation of the generation of hydrogen peroxide by
interaction ofseminal pkasma with cervical mucus
Eleven samples of cervical mucus were incubated with
lOUml ' of coilagenase and 200 sgml ' hyaluronidaw for
2-3 h at room temperature as above. The samples were
diluted 1:3 in 10mM Tris-HCI pH 7.4/150mM sodium
chloride and 151 l aliquots were assyed for PAO activity
using either 6 jg ml- 1 spermine tetrahydrochloride or seminal
plasma diluted to give a final oxidisable polyamine concen-
tration of 6 lug ml -'. The reactions were incubated for 24 h at
37C in a stoppered cuvette and assayed for hydrogen peroxide
as described above.
ReIts
Polyanine levels in semnal plasma samples
The total PAO-oxidisable polyamine content of 187 sminal
plasma samples was determined (Figure la) and found to fall
within a range equivalent to 0.0-4.8 mgml-' (0-13.8 mM)
spermine. The median value was 0.6 mgml-' (1.7mM), the
upper quartile 1.2 mg ml-' (3.5 mM) and the lower quartile
0.2 mg ml-' (0.6 mM). These values are imilar to those
determined using alternative methods designed for detecting
specific polyamines (see Janne et al., 1973; Jakobsen et al.,
1989; Oefner et al., 1992). No correlation was found between
the density and percentage motility of sperm in the onginal
semen samples and the polyamine content of the plasma as
determined by the assay. We have previously reported
evidence that individual males maintain relatively constant
Detection ofpolyamines in seminal plasma
Polyamine (spermine and spermidine) levels were determined
using the chemiluminescence assay described by Fenandez et
al. (1994) as follows: SP samples were diluted 1:60 in reac-
tion buffer (1 mM glycine hydrogen chloride pH 7.4/0.01 mM
sodium carbonate). An aliquot of 20 id of diluted SP was
mixed with 1 ml of reaction buffer in a stoppered cuvette,
10 j of purified PAO was added, and the cuvette was
incubated at room temperature for 1 h. The reaction was
completed by the addition of 20 id of 0.9 mg ml-' luminol(final concentration 18 ag ml-l) and 0.1 ml of 0.1 mg ml-'
microperoxidase (final concentration 10 jag ml '). Light emit-
ted was measured using a BioOrbit 1251 luminometer with
BioOrbit 1257 software ('Phagocytosis' programme) or a
BioOrbit 1250 luminometer linked to a standard chart
recorder. Integral values were calibrated against those
obtained using known spermine standards. Putrescine was
assayed by substituting DAO for PAO to a final concentra-
tion of lSMgml-I and incubating at 3rC for 24h.
Detection ofpolyanine and diamine oxidases in cervical mucus
Preweighed cervical mucus samples were incubated with
10 U ml-' of collaenase and 200 jg ml-' hyaluronidase for
2-3 h at room temperature. Separate expenrments were car-
ried out to determine that this pretreatment did not affect the
levels of polyamine or diamin oxidase present in the samples
(results not shown). The samples were then diluted 1:3 in
10mM Tris-HCI pH 7.4/150mm sodium chloride and assayed
for the presence of PAO and DAO using a modification of
a b c
E
0E
C
0.
a
75
a0
0
a
.2
10
S
0
m
S
* S
SeNodNonnb Abnormapllmasum pb (187) cervix cervix
Fwe 1 PAO-oxidisae poamine ls in (a) seminal plasma
samples from 187 males m ShldFeld and the USA, (b) 62 mals
whose female partners have a normal cervix and (c) 12 males
whose female partners have abnormalities of the cervix (dysplasia
and various stages of crvical intraepithdial neoplasia pooled
togehr), as determined by the d _ibn' ec assay. Each
dot esents an individual seminal plsma sample, the box
reprsmats the upper and lower quartile values and the line within
the box repr ts the median value.
Ppmanes and Ui* ozidases in hmar c ane
C Fernandez et al
1196
levels of PAO-oxidisable polyamines in SP over time (Fer-
nandez et al., 1994).
Putrescine levels were determined separately, using DAO,
in 40 seminal plasma samples. Only four of these samples
contained putrescine at concentrations detectable by this
assay (12, 24, 42 and 168 jigml-'); this diamine thus consti-
tutes a minor component of the total oxidisable polyamine
content of seminal plasma.
Relationship between polaiamine levels and abnormalities of the
cervix
Details of the state of the cervix from women attending the
Sheffield Fertility Centre whose partners provided a semen
sample were available for some, but not all, of the analyses.
Figure lb shows the distribution of PAO-oxidisable poly-
amines in the SP of 62 males whose female partners showed
no cervical abnormalities (range 0-3.1 mg ml-1; median 0.7,
upper quartile 1.2. lower quartile 0.3 mg ml-') and Figure lc
shows the values of PAO-oxidisable polyamines in the SP of
12 males whose female partners had dysplastic changes or
any stage of CIN (range 0.1 -3.0 mg ml-'; median 0.9, upper
quartile 1.2, lower quartile 0.2 mg ml-1). Statistical analysis
by the Mann-Whitney U-test did not demonstrate any
significant correlation between polyamine content of SP sam-
ples from males and the state of the cervix in their respective
female partners. However, since the number of cases showing
abnormalities of the cervix was small (n = 12), no definitive
conclusion could be drawn on the relevance of polyamine
concentration to the occurrence of abnormalities of the cer-
vix.
Extensive clinical information was collected from both
male and female partners (n = 67) attending the Department
of Family Practice, University of Michigan Medical School,
MI, USA. No correlation could be identified between the
PAO-oxidisable polyamine content of SP samples from males
as determined by the chemiluminescence assay and the occur-
rence of genital warts, HPV infection, other genital infections
including Herpes, Trichomonas, Chlanydia and Candida, cer-
vical cancer or abnormalities of the cervix of respective part-
ners. There was also no correlation between polyamine con-
tent and any other parameter concerning the male, including
smoking, ethnic group, previous history of genital warts and
genital infections such as Herpes, Trichomonas, Chlamydia
and Candida, vasectomy, or circumcision, as determined by
statistical analysis of variance (ANOVA).
Diamine oxidase and polyamine oxidase levels in cervical
mucus samples
One hundred and twenty-six cervical mucus samples were
assayed for the presence of DAO and PAO (Figure 2a and
b). DAO alone was detected in 19/126 (15.1%) of the sam-
ples, PAO alone in 271126 (21.4%), DAO plus PAO in
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Fugwe 2 (a) DAO levels detected in 126 cervical mucus samples. The figure represents the level of DAO in each sample as pmol
hydrogen peroxide generated min-' mg-' cenrical mucus as determined using the chemiluminescence assay. (b) PAO levels detected
in 126 cervical mucus samples. The figure represents the level of PAO in each sample as pmol hydrogen peroxide generated
min-' mg-' cervical mucus as determined using the chemiluminescence assay.
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18/126 (14.3%) and neither enzyme in 62/126 (49.2%). Levels
of DAO varied from undetectable to 7.0 pmol peroxide
generated min'l mg'I mucus (Figure 2a); the median of the
values in which DAO activity was detectable was 0.36 pmol
min' mg-' (upper quartile 0.83, lower quartile 0.23). PAO
levels ranged from undetectable to 0.828 pmol peroxide
generated min- Img' mucus (Figure 2b); the median of the
values in which PAO was detectable was 0.038 pmol peroxide
generated minm- mg-I mucus (upper quartile 0.079, lower
quartile 0.012). Statistical analysis of the DAO and PAO
levels in individual women who expressed detectable k-les of
both enzymes showed evidence of a lnear relationship
between DAO and PAO values (linear correlation coefficient
0.962; Figure 3).
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The results are shown in Table I. With the exception of one
specmen (sample 3), which showed a low level of PAO
activity with spermine as substrate but no activity with SP,
all the cervical mucus samples which showed detectable PAO
activity with spermine as substrate generated hydrogen
peroxide when incubated with seminal plasma, indicating
that semen does not contain significnt levels of inhibitors of
polyamine oxidases. Interestingly, the levels of hydrogen
peroxide generated by cervial mucus in reaction with
seminal plasma were higher than those generated with sper-
mine alone, indicating either that the polyamines in seminal
plama are better substrates for the enzyme (perhaps owing
to the presence of an enzyme co-factor) or that the hydrogen
peroxide generated is stabilised by a component of semen.
Generation of hydrogen peroxide in the interaction between
semina plasma and cervical mucus
In order to test whether cervical mucus polya
enzymes are still active in the presence of se
estimations of the levels of hydrogen peroxid
cervical mucus oxidases were carried out
plasma as a source of substrate in place of pu
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FLgwe 3 Distribution of 126 cervical mucus saml
PAO and/or DAO, as determined by the chez
assay. DAO and PAO leves are represented as I
peroxide generated min' mg' cervical mucus and
a log scale for clarity. Cervical mucus samples witl
table presence of either PAO or DAO (n = 62) are
a singl dot at the interstion in the above gn
samples contain DAO only, 27 mucus samples con
and 18 mucus samples contain both enzymes.
Tabe I Eklven cervical mucus samples assayed for
absence of PAO
PAO
(pmol hydrogen peroxide g
Cervical mucus m- mg-I mucus)
sanpk Spermine tetrachloride Sen
1 0.105
2 0.054
3 0.004
4 0.002
5 0
6 0.044
7 0.116
8 0
9 0.089
10 0.021
11 0.037
Either spermine tetrachloride (6 pg ml-l final a
seminal plasma (6 pg ml-' PAO-oxidisable polyami
substrate in thec l nce assay. Values re
of PAO as pmol hydrogen peroxide generated min
mucus.
umine-oxidising Oxidisable polyamine levels were determined in 187 samples
minal plasma, of seminal plasma using a novel chemiluminescence assay
e generated by (Fenandez et al., 1994). The results were similar to those
using seminal determined by other published methods: PAO-oxidisable
rified spermine. polyamine levels ranged from undetectable to as high as
4.8 mg ml-'. Only 4 out of 40 samples displayed measurable
levels of putrescine, with the highest concentration being
168pgmIg1. Putrescine has previously been found in trace
o amounts in SP samples, with levels up to 200Wgml-I
0 (Jakobsen et al., 1989). In the context of risk factors for
o cervical carcinoma, the total content of oxidisable polyamme
in SP is probably more relevant than individual polyamine
0 concentrations.
In a previous study (Femandez et al., 1994) we showed
that individual men maintain high or low levels of SP
polyamines over time: oxidisable polyamine concentrations
rmained relatively constant in individual males when semen
samples were collected following 2 days abstinence. In the
present study we found no signficant difference in the range
of polyamine levels between SP samples from normospermic
and oligospermic semen. Although aspermic semen has been
shown to contain lower spermine levels than normospermic
W-0-0-1 (Shohat et al., 1989; Singer et al., 1989), Shohat et al. did not
1 10 find any signiicant differences in spermine content between
oligo- and normospermac semen.
The immunosuppressive and cytotoxic effects of
pks contamg polyamines in SP are largely dependent on the products of
nil hye their oxidation by PAO and/or DAO. We found measurable
arepbnol d on levels of one or both of these enzymes in over half of the 126
hout te detc- cervical mucus samples assayed. The presence of these
represented by enzymes within the female genital tract has not been reported
aph, 19 mucus previously, except for the detection of DAO in vaginal secre-
tain PAO only tions as a marker for ruptured amnionic membranes (Bank et
al., 1991; Broe et al., 1992). The variations in PAO and DAO
expression between individuals may be genetically ihrent,
or may simply reflect different time points within the mens-
rthe prmeseC or trual cycle (van der Linden et al., 1992). In addition, PAO
and DAO activity in the cervi mucus of some individuals
might be inhibited by serum components difsing into the
renerated fluids surrounding the cervix (Quan et al., 1991). The pattern
of expression of the two enzymes shown in Figure 3 suggests
PWpa"" that the enzymes may be coordinately regulated when both
0.896 are present, but that the presence or absence of each is
1.491 independent of the other. Further studies are required to
0 determine whether enzyme lvels are constitutively linked and0.538 whether they remain constant within individual females
0 through the menstrual cycle and over longer time periods.1.101 Mixing of SP with cervical mucus in vitro leads to the0.666
generation of highlevels of hydrogen peroxide. PAO and0
0.683 DAO in mucus are thus fuly active against polyamines in
0.062 SP. During intercourse in the absnce of physical barrier
0.688 contraception, when SP comes into contact with cervical
oncentration) or mucus, polyamines in the SP will be oxidised to generate
nes) are used as hydrogen peroxide, aldehydes and other toxic products.
present the level Complete mixing of SP with an equal volume of cervical
- 'mg-' cervical mucus containing polyamine oxidase actity of 1 pmol
min-' mg- could kad to micromolar levels of peroxide after
0q I%mv -4
Polyanunes and eir oxidases in human cerici cancer
C Fernandez et al
11X3
2 min (in the absence of peroxidases). The effects of exposing
cells to peroxide and oxygen radicals include random DNA
strand breaks (Henle et al.. 1986) and chromatid aberrations
(Bouzyk and Rosiek. 1988). as well as inhibition of cellular
proliferation (Averill-Bates et al.. 1993) and suppression of
immune functions (Alexander and Anderson, 1987). Pro-
grammed cell death, which is triggered by p53-dependent
genomic surveillance mechanisms, is also induced by peroxide
(Parchment and Pierce, 1989; Gramzinski et al., 1990),
presumably as a result of DNA damage. Apoptosis should
protect the cervix from the potentially dangerous effects of
individual cells containing mutated oncogenes or tumour-
suppressor genes. However, the HPV E6 and E7 genes
interact with p53 and RB-1 proteins respectively (Chen and
Defendi, 1992: Scheffner et al.. 1992: Stirdivant et al., 1992),
and thus HPV infection may interfere with induction of
programmed cell death in infected cells, enhancing the sur-
vival of precancerous clones. Lowered local immune surveil-
lance resulting from the immunosuppressive effects of
polyamine oxidation products may also assist in this survival.
We have shown that exposure of keratinocytes in vitro to
hydrogen peroxide at micromolar levels induces apoptosis,
while exposure to higher levels (100-200 Am) leads to cell
death through direct toxicity; transfection of cells with the E6
gene of HPV18 suppressed the apoptotic component of this
response, while death through direct toxicity was unaffected
(RM Sharrard, C Fernandez and VB Watt, manuscript in
preparation).
A synergistic interaction may thus occur in women who
express (sporadically or constitutively) high levels of
polyamine-oxidising enzymes. who harbour cervical HPV and
who have regular unprotected sex with one or more partners
whose semen contains moderate or high levels of polyamines,
leading to increased risk of cervical cancer. This hypothesis
does not require persisent HPV infection for the full period
between the initiation of the tumorigenic process and the
development of clinically detectable cancer; indeed, HPV
infections have been found to persist for shorter times than
once thought (Hildesheim et al.. 1994). HPV infection would
inhibit apoptosis in cervical cells at the time of the initial
genomic damage, leading to their inappropriate survival. A
proportion of these cells might then acquire further damage.
either through further exposure to environmental mutagens
or through genomic instability resulting from the initial
damage (together with the effects of other HPV genes). Once
a certain level of genomic damage had been established,
especially if the regulation of proliferation vs apoptosis had
been disrupted. HPV could be lost without reversion of the
cells to normality.
In the present study. examination of the relationship of
diverse polyamine levels in SP in relation to the presence of
cervical abnormalities did not demonstrate any correlation
between oxidisable polyamine levels in the male and the
presence of cervical abnormalities in the female partner.
However. the physiological effects of initial carcinogenic
events may take 20 years to become clinically manifest. and
demonstration of the mechanisms related to these events will
require long-term prospective investigations. We are presently
carrying out a larger study of PAO and DAO levels in
women with and without cervical disease in order to deter-
mine whether high levels of one or both enzymes are at
increased risk of dysplasia or neoplasia of the cervix. Our
laboratory is also developing in vitro model systems for
assessment of the potential tumorigenic synergy between
seminal plasma polyamines. the presence of oxidases. and the
expression within target keratinocytes of HPV E6 and E7
genes. If this synergy were proven, women who express high
levels of the oxidases could be advised to use physical barrier
methods of contraception to reduce their risk of cervical
cancer. Screening sexually active women for the presence of
PAO and DAO with the relatively simple assay system used
in the present study (for example. simultaneously with
routine cervical smear testing) could thus prove valuable in
identifying and counselling women who may be at increased
risk of cervical cancer.
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